For this indication, competent medicine agencies globally authorize below treatments:
Oral
2.5 - 10 mg
From 2.5 To 10 mg once every day
2.5-10 mg daily for 5-10 days commencing on the assumed or calculated 16th – 21st day of the cycle. Treatment should be given for two consecutive cycles. When bleeding occurs from a poorly developed proliferative endometrium, conventional oestrogen therapy may be employed in conjunction with medroxyprogesterone acetate in doses of 5-10 mg for 10 days.